Untargeted LC-HRMS Based-Plasma Metabolomics Reveals 3-O-Methyldopa as a New Biomarker of Poor Prognosis in High-Risk Neuroblastoma
暂无分享,去创建一个
L. Oneto | P. Uva | A. Garaventa | D. Cangelosi | A. Eva | G. Tripodi | A. Petretto | Martina Morini | M. Conte | S. Barco | G. Cangemi | C. Lavarello | Davide Cangelosi